INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
26/02/2026
Voltar para busca
Dado oficial do USPTO
CONSUN
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
43
Atualização mais recente
27/02/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5
Data de depósito
16/04/2018
Data de registro
21/05/2019
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
12/11/2024
Última transação
27/02/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
706
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
Guangdong Province, CN
Examinador
CHHINA, KARANENDRA S
Localização atual
POST REGISTRATION
Descrição da marca
The mark consists of the stylized Chinese character "REN" which is above the horizon line as well as the words "CONSUN" and two Chinese characters which are vertically arranged beneath the horizon line and "CONSUN".
Titulares e representantes
Titulares
Guangzhou Consun Pharmaceutical Co., Ltd
Representantes
John G. Tutunjian Tutunjian & Bitetto, P.C.
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Chinese medicines for circulating the blood, relaxing the muscles and joints, reducing swelling and pain, treating bruises, eliminating fatigue before and after sports; medicines for human purposes for circulating the blood, relaxing the muscles and joints, reducing swelling and pain, treating bruises, eliminating fatigue before and after sports; chemico-pharmaceutical preparations for circulating the blood, relaxing the muscles and joints, reducing swelling and pain, treating bruises, eliminating fatigue before and after sports; drugs for medical purposes for circulating the blood, relaxing the muscles and joints, reducing swelling and pain, treating bruises, eliminating fatigue before and after sports; Pharmaceutical preparations for circulating the blood, relaxing the muscles and joints, reducing swelling and pain, treating bruises, eliminating fatigue before and after sports; [ liquid medicines for headaches, heart conditions, blood pressure; medicines, namely, tablets for relieving pain; ] biochemical medicines for circulating the blood, relaxing the muscles and joints, reducing swelling and pain, treating bruises, eliminating fatigue before and after sports [; medicines, namely, paste for circulating the blood, relaxing the muscles and joints, reducing swelling and pain, treating bruises, eliminating fatigue before and after sports; medicines, namely, injection for headaches, heart conditions, blood pressure ]
Publicações
Histórico de despachos e eventos da marca no USPTO.
43 publicações encontradas
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
02/01/2026
XXCR
GENERIC MADRID TRANSACTION CREATED
02/01/2026
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
12/07/2025
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
12/11/2024
71AG
REGISTERED-SEC.71 ACCEPTED
12/11/2024
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
05/11/2024
PUM1
OFFICE ACTION ISSUED POU1
07/08/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/08/2024
ES71
TEAS SECTION 71 RECEIVED
08/07/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/07/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/07/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/07/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/07/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/07/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
21/05/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/06/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
15/11/2019
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
06/09/2019
XXCR
GENERIC MADRID TRANSACTION CREATED
06/09/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
21/08/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
21/05/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/03/2019
PUBO
PUBLISHED FOR OPPOSITION
05/03/2019
GPNX
NOTIFICATION PROCESSED BY IB
02/03/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
13/02/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
13/02/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
13/02/2019
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
22/01/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/01/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
22/12/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/12/2018
ALIE
ASSIGNED TO LIE
22/12/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
19/12/2018
RFNT
REFUSAL PROCESSED BY IB
21/09/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/09/2018
RFRR
REFUSAL PROCESSED BY MPU
03/09/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
22/08/2018
CNRT
NON-FINAL ACTION WRITTEN
21/08/2018
DOCK
ASSIGNED TO EXAMINER
02/08/2018
MAFR
APPLICATION FILING RECEIPT MAILED
31/07/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
27/07/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
26/07/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CONSUN ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.